END OF CANCER:NEWLY IMPROVED DRUG TREATS BREAST CANCER

The FDA has approved a new treatment for women with breast cancer caused by the BRCA mutation , which Angelina Jolie famously attributed to her preventive double mastectomy.

According to a press release by the Food and Drug Administration , the drug , Lynparza , was approved for patients whose breast cancer has metastasized and who carry a mutation in the BRCA 1 and BRCA 2 genes .

The genes ’ purpose is to repair damaged DNA and keep cells healthy ; however , when they don’ t function properly, the odds of developing breast or ovarian cancer increase significantly .
Explaining that she carried a “ faulty ” gene inherited from her mother, who died of cancer at age 56 , Jolie wrote , “ My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer , although the risk is different in the case of each woman.

“ Only a fraction of breast cancers result from an inherited gene mutation . Those with a defect in BRCA 1 have a 65 percent risk of getting it , on average . ”
Describing the eight - hour procedure to remove breast tissue as a “ scene out of a science - fiction film , ” Jolie wrote of the aftermath , “ On a personal note , I do not feel any less of a woman. I feel empowered that I made a strong choice that in no way diminishes my femininity . ”











Source: punchng